Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 5 studies | 47% ± 23% | |
cardiac muscle cell | 4 studies | 22% ± 2% | |
GABAergic neuron | 4 studies | 43% ± 16% | |
astrocyte | 4 studies | 37% ± 16% | |
oligodendrocyte precursor cell | 4 studies | 27% ± 8% | |
endothelial cell | 3 studies | 20% ± 3% | |
oligodendrocyte | 3 studies | 29% ± 14% | |
interneuron | 3 studies | 42% ± 19% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 5 studies | 40% ± 19% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 269.68 | 245 / 245 | 99% | 10.23 | 499 / 502 |
esophagus | 100% | 285.85 | 1441 / 1445 | 99% | 8.19 | 181 / 183 |
thymus | 100% | 429.41 | 653 / 653 | 98% | 8.16 | 594 / 605 |
brain | 99% | 331.10 | 2620 / 2642 | 99% | 5.24 | 695 / 705 |
kidney | 100% | 416.91 | 89 / 89 | 97% | 8.08 | 878 / 901 |
breast | 100% | 296.68 | 458 / 459 | 97% | 9.42 | 1083 / 1118 |
stomach | 99% | 184.49 | 354 / 359 | 97% | 6.48 | 276 / 286 |
pancreas | 100% | 277.35 | 327 / 328 | 95% | 4.50 | 169 / 178 |
lung | 96% | 197.42 | 556 / 578 | 98% | 5.71 | 1132 / 1155 |
intestine | 99% | 230.26 | 955 / 966 | 95% | 5.74 | 502 / 527 |
uterus | 100% | 235.74 | 170 / 170 | 94% | 5.55 | 430 / 459 |
ovary | 97% | 162.28 | 174 / 180 | 96% | 5.95 | 413 / 430 |
bladder | 100% | 221.10 | 21 / 21 | 90% | 5.21 | 455 / 504 |
liver | 100% | 320.28 | 226 / 226 | 85% | 4.01 | 346 / 406 |
skin | 98% | 240.81 | 1781 / 1809 | 85% | 5.24 | 401 / 472 |
adrenal gland | 100% | 414.98 | 258 / 258 | 75% | 3.68 | 173 / 230 |
muscle | 100% | 717.14 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 205.13 | 241 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 303.87 | 1332 / 1335 | 0% | 0 | 0 / 0 |
adipose | 99% | 227.07 | 1195 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 6.15 | 44 / 45 |
heart | 96% | 625.26 | 828 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 76% | 2.99 | 22 / 29 |
eye | 0% | 0 | 0 / 0 | 49% | 2.10 | 39 / 80 |
peripheral blood | 40% | 128.59 | 374 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006400 | Biological process | tRNA modification |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0016432 | Molecular function | tRNA-uridine aminocarboxypropyltransferase activity |
Gene name | DTWD2 |
Protein name | tRNA-uridine aminocarboxypropyltransferase (EC 2.5.1.25) tRNA-uridine aminocarboxypropyltransferase 2 (EC 2.5.1.25) (DTW domain-containing protein 2) |
Synonyms | |
Description | FUNCTION: Catalyzes the formation of 3-(3-amino-3-carboxypropyl)uridine (acp3U) at position 20a in the D-loop of several cytoplasmic tRNAs (acp3U(20a)) . Also has a weak activity to form acp3U at position 20 in the D-loop of tRNAs (acp3U(20)) . . |
Accessions | D6REE2 Q8NBA8 ENST00000506980.2 ENST00000510708.6 [Q8NBA8-1] D6RBD8 ENST00000304058.8 [Q8NBA8-2] ENST00000515439.7 |